or Try an Advanced Search...

    Technical Analysis for TIL - Instil Bio, Inc.

    Grade Last Price % Change Price Change
    C 10.30 0.10% 0.01
    TIL closed up 0.1 percent on Monday, July 1, 2024, on 73 percent of normal volume.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Up
    Historical TIL trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    MACD Bullish Signal Line Cross Bullish 0.00%
    Calm After Storm Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Up 3 Days in a Row Strength 0.00%
    20 DMA Resistance Bearish 0.10%
    Stochastic Buy Signal Bullish 0.10%
    Cup with Handle Other 0.10%
    Inside Day Range Contraction 0.10%
    Oversold Stochastic Weakness 0.10%
    Older End-of-Day Signals for TIL ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 6 hours ago
    Up 2% about 8 hours ago
    Up 1% about 8 hours ago
    Rose Above 20 DMA about 8 hours ago
    1.5x Volume Pace about 8 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    TIL Chart by TradingView
    Basic chart:

    Profile

    Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 (FOLR1) with indications, including gynecological, non-small cell lung cancer, and others. The company was incorporated in 2018 and is based in Dallas, Texas.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Cancer Clinical Medicine Oncology Cancer Immunotherapy Cell Therapy Non Small Cell Lung Cancer Melanoma Lymphocytes Cervical Cancer Head And Neck Squamous Cell Carcinoma Tumor Infiltrating Lymphocytes Cutaneous Squamous Cell Carcinoma Therapies For The Treatment Of Patients With Cancer

    Is TIL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 10 Instil Bio reports Q1 results
    May 10 Instil Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
    Apr 12 Jefferies cuts Instill Bio to hold, cites drug discontinuation
    Mar 27 What Makes Instil Bio (TIL) a New Buy Stock
    Mar 22 Instil Bio Non-GAAP EPS of -$1.26 beats by $2.14
    Mar 21 Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
    Jan 18 Instil (TIL) Stock Rises More Than 20% in a Week: Here's Why
    Jan 17 Instil Bio hits four-month high on rising volumes
    Jan 16 Instil Bio Announces Strategic Update
    See more TIL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 12.98
    52 Week Low 6.07
    Average Volume 8,772
    200-Day Moving Average 9.59
    50-Day Moving Average 10.81
    20-Day Moving Average 10.34
    10-Day Moving Average 10.01
    Average True Range 0.53
    RSI (14) 47.37
    ADX 14.13
    +DI 20.49
    -DI 16.06
    Chandelier Exit (Long, 3 ATRs) 9.83
    Chandelier Exit (Short, 3 ATRs) 11.21
    Upper Bollinger Bands 11.10
    Lower Bollinger Band 9.58
    Percent B (%b) 0.47
    BandWidth 14.70
    MACD Line -0.25
    MACD Signal Line -0.26
    MACD Histogram 0.0169
    Fundamentals Value
    Market Cap 66.99 Million
    Num Shares 6.5 Million
    EPS -30.20
    Price-to-Earnings (P/E) Ratio -0.34
    Price-to-Sales 55329.79
    Price-to-Book 0.32
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 10.74
    Resistance 3 (R3) 10.76 10.63 10.67
    Resistance 2 (R2) 10.63 10.52 10.62 10.64
    Resistance 1 (R1) 10.47 10.45 10.55 10.45 10.62
    Pivot Point 10.34 10.34 10.38 10.33 10.34
    Support 1 (S1) 10.17 10.23 10.26 10.15 9.98
    Support 2 (S2) 10.04 10.16 10.03 9.96
    Support 3 (S3) 9.88 10.04 9.93
    Support 4 (S4) 9.86